Lv5
1160 积分 2024-10-19 加入
Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway
1个月前
已完结
7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo
1个月前
已完结
The gut-liver axis in liver disease: Pathophysiological basis for therapy
5个月前
已完结
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
5个月前
已完结
Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis
6个月前
已完结
A gut-vascular barrier controls the systemic dissemination of bacteria
6个月前
已完结
Wnt/β-catenin信号通路参与氧化应激的调控以及对造血系统影响的研究进展
6个月前
已完结
Mechanistic Exploration of Dahuang Zhechong Pill Against Hepatic Fibrosis via Integrated Serum Pharmacochemistry, UHPLC-ESI-QTOF-MS/MS, Network Pharmacology, and Molecular Docking with Cellular and Zebrafish Validation
9个月前
已完结
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
9个月前
已完结
Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway
9个月前
已完结
皖公网安备34019202002308